Kethiri; Raghava Reddy
Patent Applications and Registrations
Patent applications and USPTO patent grants for Kethiri; Raghava Reddy.The latest application filed is for "anti-infective heterocyclic compounds and uses thereof".
- Kethiri; Raghava Reddy - Bangalore IN
- KETHIRI; Raghava Reddy - Subramanyapura IN
- KETHIRI; Raghava Reddy - London GB
- Kethiri; Raghava Reddy - Noida IN
| Patent | Date |
|---|---|
| Anti-infective heterocyclic compounds and uses thereof Grant 11,130,741 - Kirsebom , et al. September 28, 2 | 2021-09-28 |
| Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer Grant 11,103,491 - Venkatesan , et al. August 31, 2 | 2021-08-31 |
| Anti-infective Heterocyclic Compounds And Uses Thereof App 20210246115 - Kirsebom; Leif ; et al. | 2021-08-12 |
| Chemical compounds Grant 10,851,053 - Axten , et al. December 1, 2 | 2020-12-01 |
| Chemical Compounds App 20200297710 - AXTEN; Jeffrey Michael ; et al. | 2020-09-24 |
| Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer Grant 10,751,332 - Venkatesan , et al. A | 2020-08-25 |
| Heterocyclic Inhibitors Of Erk1 And Erk2 And Their Use In The Treatment Of Cancer App 20200179356 - Venkatesan; Aranapakam M. ; et al. | 2020-06-11 |
| Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer Grant 10,471,051 - Venkatesan , et al. Nov | 2019-11-12 |
| Chemical Compounds App 20190298705 - AXTEN; Jeffrey Michael ; et al. | 2019-10-03 |
| Isoquinoline Derivatives As Perk Inhibitors App 20190241573 - AXTEN; Jeffrey Michael ; et al. | 2019-08-08 |
| Anti-infective Heterocyclic Compounds And Uses Thereof App 20190233384 - Kirsebom; Leif ; et al. | 2019-08-01 |
| Chemical Compounds App 20190144384 - AXTEN; Jeffrey Michael ; et al. | 2019-05-16 |
| Substituted pyrimidine compounds, compositions and medicinal applications thereof Grant 10,273,224 - Venkateshappa , et al. | 2019-04-30 |
| Chemical Compounds App 20180237441 - AXTEN; Jeffrey Michael ; et al. | 2018-08-23 |
| Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer Grant 9,896,445 - Venkatesan , et al. February 20, 2 | 2018-02-20 |
| Heterocyclic Inhibitors Of Erk1 And Erk2 And Their Use In The Treatement Of Cancer App 20170362216 - Venkatesan; Aranapakam M. ; et al. | 2017-12-21 |
| Pyridine Derivatives App 20170073339 - Smith; Roger A. ; et al. | 2017-03-16 |
| Pyridine derivatives Grant 9,533,981 - Smith , et al. January 3, 2 | 2017-01-03 |
| Pyridine Derivatives App 20160340310 - Smith; Roger A. ; et al. | 2016-11-24 |
| Compounds For Regulating Fak And/or Src Pathways App 20160222014 - Venkatesan; Aranapakam M. ; et al. | 2016-08-04 |
| Substituted Pyrimidine Compounds, Compositions And Medicinal Applications Thereof App 20160207905 - VENKATESHAPPA; CHANDREGOWDA ; et al. | 2016-07-21 |
| Pyridine derivatives Grant 9,371,316 - Smith , et al. June 21, 2 | 2016-06-21 |
| Pyridine derivatives Grant 9,266,873 - Smith , et al. February 23, 2 | 2016-02-23 |
| Biaryl imidazole derivatives for regulating CYP17 Grant 9,199,975 - Smith , et al. December 1, 2 | 2015-12-01 |
| Pyridine Derivatives App 20140378511 - Smith; Roger Astbury ; et al. | 2014-12-25 |
| Pyridine Derivatives App 20140364462 - Smith; Roger Astbury ; et al. | 2014-12-11 |
| Pyridine derivatives Grant 8,809,372 - Smith , et al. August 19, 2 | 2014-08-19 |
| Pyridine Derivatives App 20130085148 - Smith; Roger Astbury ; et al. | 2013-04-04 |
| Imidazole Derivatives App 20130085164 - Smith; Roger Astbury ; et al. | 2013-04-04 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 